EssilorLuxottica Société anonyme (EPA:EL)
France · Delayed Price · Currency is EUR 276.90
+0.90 (0.33%)
Oct 1, 2025, 5:35 PM CET
EPA:EL Revenue
EssilorLuxottica Société anonyme had revenue of 14.02B EUR in the half year ending June 30, 2025, with 9.13% growth. This brings the company's revenue in the last twelve months to 27.24B, up 5.45% year-over-year. In the year 2024, EssilorLuxottica Société anonyme had annual revenue of 26.51B with 4.38% growth.
Revenue (ttm)
27.24B
Revenue Growth
+5.45%
P/S Ratio
4.69
Revenue / Employee
136.16K
Employees
153,498
Market Cap
127.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.51B | 1.11B | 4.38% |
| Dec 31, 2023 | 25.40B | 901.00M | 3.68% |
| Dec 31, 2022 | 24.49B | 4.67B | 23.58% |
| Dec 31, 2021 | 19.82B | 5.39B | 37.36% |
| Dec 31, 2020 | 14.43B | -2.96B | -17.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.74B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 4.12B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 6.02M |
| Virbac | 1.43B |
| emeis Société anonyme | 5.77B |
EssilorLuxottica Société anonyme News
- 10 hours ago - EssilorLuxottica completes acquisition of Optegra - GlobeNewsWire
- 6 days ago - EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States - GlobeNewsWire
- 14 days ago - EssilorLuxottica: EssilorLuxottica and Meta build on their successful partnership with new AI glasses that offer a glimpse into the future - GlobeNewsWire
- 15 days ago - EssilorLuxottica: Further Outperformance Since 2023 (Rating Downgrade) - Seeking Alpha
- 19 days ago - Giorgio Armani’s will says his brand should be sold or seek IPO - The Guardian
- 5 weeks ago - Nikon (7731) Shares Surge as EssilorLuxottica Explores Increasing Stake - GuruFocus
- 5 weeks ago - Meta To Launch First Consumer Smart Glasses With Display, Gesture-Control Wristband At Connect Conference: Report - Benzinga
- 2 months ago - EssilorLuxottica: EssilorLuxottica acquires Automation & Robotics, advancing high-performance solutions in ophthalmic manufacturing - GlobeNewsWire